DNA-binding domain fusions enhance the targeting range and precision of Cas9

The CRISPR-Cas9 system is commonly employed in biomedical research; however, the precision of Cas9 is sub-optimal for gene therapy applications that involve editing a large population of cells. Variations on the standard Cas9 system have yielded improvements in the precision of targeted DNA cleavage...

Descripción completa

Detalles Bibliográficos
Autores principales: Bolukbasi, Mehmet Fatih, Gupta, Ankit, Oikemus, Sarah, Derr, Alan G., Garber, Manuel, Brodsky, Michael H., Zhu, Lihua Julie, Wolfe, Scot A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4679368/
https://www.ncbi.nlm.nih.gov/pubmed/26480473
http://dx.doi.org/10.1038/nmeth.3624

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4679368/
https://www.ncbi.nlm.nih.gov/pubmed/26480473
http://dx.doi.org/10.1038/nmeth.3624

Ejemplares similares